Novel Antibody Prevents Infection By Hepatitis C Virus, Massachusetts Biologic Laboratories Study
5/5/2009 11:56:39 AM
More...
|
Merck & Co., Inc. (MRK) Signs Licensing Deal; Medarex, Inc. (MEDX) and Massachusetts Biologic Laboratories to Get Payments up to $165 Million
4/21/2009 7:14:52 AM
More...
|
Medarex, Inc. (MEDX) and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea
11/3/2008 9:33:15 AM
More...
|
Akorn, Inc. (AKN) Signs Exclusive Distribution Agreement With Massachusetts Biologic Laboratories For Tetanus Diphtheria Vaccine
3/27/2007 1:20:30 PM
More...
|
Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories Announce Commencement Of Phase II Clinical Trial Of Anti-C. difficile Antibody Combination For The Treatment Of Hospital Acquired Diarrhea
9/6/2006 10:56:18 AM
More...
|
Sinovac Biotech Ltd. (SNVBF) To Test Fully Human Antibody Developed By Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories For Its Ability To Neutralize The SARS Virus
10/19/2005 5:11:03 PM
More...
|
Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories Release: SARS Antibody Sent To China For Preclinical Testing
10/19/2005 5:11:03 PM
More...
|
Massachusetts Biologic Laboratories And Medarex, Inc. (MEDX) Announce Phase I Clinical Trial Of A Novel Fully Human Antibody For The Treatment Of Hospital Acquired Diarrhea
10/19/2005 5:09:13 PM
More...
|